Apollo and KKR Provide €3 Billion Capital Solution for Bayer's LARC Business

Funds managed by Apollo, with KKR as a significant minority participant, have successfully finalized a €3 billion capital solution for Bayer. This investment supports a newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business. Bayer will retain a majority stake and full operational control, providing substantial capital while maintaining its core business segment.